Changeflow GovPing Pharma & Life Sciences

Recent changes

GovPing monitors 142 sources for this role across Guidance, Enforcement, Rule, Notice, and Consultation, out of 2,503 total sources on the platform. The past week saw 602 changes across these sources.

FDA issued a Warning Letter to Purolea Cosmetics Lab for CGMP violations, while also warning Dry Springs Pharmacy for unlawful opioid sales. A Class I recall of Philips Trilogy Evo ventilators highlights a serious device safety issue. The Class I recall of Draeger Atlan A350 anesthesia workstations further underscores critical equipment risks.

No changes tracked yet for Pharma & Life Sciences.

Sources are being set up. Changes will appear here as they're detected.

RSS

Get daily alerts for pharma & life sciences

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Filters

139 official sources tracked

Regs.gov: Food and Drug Administration

Updated 4m ago

USPTO Trademarks - Pharmaceuticals (Class 005)

Updated 12d ago

USPTO Patent Applications - Pharma (A61K)

Updated 3d ago

USPTO Patent Applications - Biotech (C12N)

Updated 1d ago

USPTO Patent Applications - Peptides (C07K)

Updated 3d ago

USPTO Patent Applications - Organic Chemistry (C07D)

Updated 5d ago

USPTO Patent Applications - Therapeutics (A61P)

Updated 3d ago

USPTO Patent Grants - Therapeutics (A61P)

Updated 19m ago

USPTO Patent Grants - Organic Chemistry (C07D)

Updated 1d ago

USPTO Patent Grants - Peptides (C07K)

Updated 1d ago

ANSM Drug & Device Safety Alerts

Updated 4m ago

FR: National Institutes of Health

Updated 33m ago

Health Canada Recalls & Safety Alerts

Updated 6m ago

Regs.gov: Centers for Medicare and Medicaid Services

Updated 7m ago

FR: Health and Human Services Department

Updated 15m ago

CPSC Product Recalls

Updated 7m ago

FR: Food and Drug Administration

Updated 22m ago

FDA Warning Letters

Updated 3m ago

FR: Drug Enforcement Administration

Updated 13d ago

MHRA Guidance & Safety

Updated 1d ago

WHO News

Updated 1d ago

CMS Newsroom

Updated 6d ago

FR: Centers for Disease Control and Prevention

Updated 2d ago

FR: Centers for Medicare & Medicaid Services

Updated 17m ago

Regs.gov: Occupational Safety and Health Administration

Updated 2d ago

DEA Press Releases

Updated 27m ago

EPO Patent Bulletin - Pharma (A61K)

Updated 23m ago

FDA Medical Device Recalls

Updated 10m ago

HSA Singapore Announcements

Updated 22m ago

DEA Public Safety Alerts

Updated 7d ago

Regs.gov: Animal and Plant Health Inspection Service

Updated 6d ago

FDA Recalls & Safety Alerts

Updated 1d ago

Saudi SFDA News

Updated 2d ago

Regs.gov: Centers for Disease Control and Prevention

Updated 2d ago

HHS OIG Reports & Publications

Updated 13d ago

FR: Health Resources and Services Administration

Updated 6m ago

Regs.gov: Food Safety and Inspection Service

Updated 12d ago

ANSM France News

Updated 11m ago

FDA Press Releases

Updated 2d ago

NH Board of Pharmacy Actions

Updated 13d ago

USP Compendial Notices

Updated 13d ago

WV Board of Pharmacy

Updated 11d ago

LA Board of Pharmacy News

Updated 28d ago

MS Board of Pharmacy News

Updated 28d ago

BfArM Drug Safety Communications

Updated 4d ago

PMPRB

Updated 25m ago

FDA AI-Enabled Medical Devices

Updated 24d ago

UK VMD

Updated 19m ago

GA Board of Pharmacy Board Orders

Updated 23d ago

FDA Guidance Documents

Updated 1d ago

EPO Patent Bulletin - Therapeutics (A61P)

Updated 37m ago

ECHA News

Updated 15d ago

KS Board of Pharmacy Newsletters

Updated 21d ago

FDA Debarment List

Updated 10d ago

ID Board of Pharmacy

Updated 29d ago

MA Pharmacy Practice Resources & Guidance

Updated 20d ago

EMA News

Updated 16d ago

FDA MedWatch Safety Alerts

Updated 22d ago

KY Board of Pharmacy

Updated 28d ago

IA Board of Pharmacy News

Updated 21d ago

Frequently asked questions

What does this feed cover?

FDA warning letters, novel drug approvals, drug shortage notices, ICH guideline updates, USP notices, EMA news, DEA scheduling decisions, and TGA/WHO standards.

Who is this for?

Regulatory affairs professionals, pharmacovigilance teams, and medical affairs groups at pharma companies and CROs who need to track FDA and EMA actions.

How often is this updated?

GovPing checks source pages multiple times daily. FDA warning letters and drug approvals typically appear within hours of publication.

Does this cover EMA and international regulators?

Yes. We monitor the EMA, ICH, WHO, TGA (Australia), and other international health authorities alongside FDA.

How is this different from AgencyIQ?

AgencyIQ is a full FDA intelligence platform. GovPing is a free feed of the FDA, EMA, and ICH source pages where warning letters, approvals, drug shortages, and guidance are first published - AI-summarized with attention-level ratings on every change.

Is GovPing free?

Yes. GovPing is free, and always will be. We believe government regulatory data should be accessible to everyone. For custom monitoring of pages we don't cover yet, Changeflow starts at $99/mo.

Need to monitor something else?

GovPing covers the common sources. For niche pages specific to your team, add custom URL monitoring with Changeflow.

Get Pharma & Life Sciences alerts

Daily digest of pharma & life sciences regulatory changes. AI-summarized, no noise.

Free. Unsubscribe anytime.